Osiris Therapeutics (OSIR) Misses Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Total operating expenses: 19.63M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Total operating expenses: 19.63M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q3 EPS of ($0.02), $0.08 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $24.3 million versus the consensus estimate of $25.4 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- SanDisk stock tumbles as Kioxia warns on NAND price surge
- Top oil & gas exploration stocks, according to Mizuho
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
